भारत - अंग्रेज़ी - Central Drugs Standard Control Organization

epitome - cefpodoxime - d.syr - 50mg/5ml - 30ml

भारत - अंग्रेज़ी - Central Drugs Standard Control Organization

epitome - cefpodoxime - dt tab - 100/200;mg - 50/50

भारत - अंग्रेज़ी - Central Drugs Standard Control Organization

epitome - cefpodoxime - dt tab - 50mg - 100

भारत - अंग्रेज़ी - Central Drugs Standard Control Organization

epitome - rabeprazole,domperidone - dm tab - 20,10;mg - 100

भारत - अंग्रेज़ी - Central Drugs Standard Control Organization

epitome - rabeprazole,domperidone - tab - 20,10(sr);mg - 100

सिंगापुर - अंग्रेज़ी - HSA (Health Sciences Authority)

johnson & johnson international (singapore) pte ltd - epoprostenol sodium 0.531mg eqv epoprostenol - injection, powder, for solution - epoprostenol sodium 0.531mg eqv epoprostenol 0.5mg

सिंगापुर - अंग्रेज़ी - HSA (Health Sciences Authority)

johnson & johnson international (singapore) pte ltd - epoprostenol sodium 1.593mg eqv epoprostenol - injection, powder, for solution - epoprostenol sodium 1.593mg eqv epoprostenol 1.5mg

न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - epoprostenol sodium 1.593mg equivalent to epoprostenol 1.5 mg - powder for injection - 1.5 mg - active: epoprostenol sodium 1.593mg equivalent to epoprostenol 1.5 mg excipient: arginine sodium hydroxide sucrose - veletri is indicated for the long-term treatment, via continuous intravenous infusion, in who functional class iii and iv patients with: · idiopathic pulmonary arterial hypertension · familial pulmonary arterial hypertension · pulmonary arterial hypertension asscociated with the scleroderma spectrum of diseases.

न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - epoprostenol sodium 531ug equivalent to epoprostenol 500 mcg - powder for injection - 500 mcg - active: epoprostenol sodium 531ug equivalent to epoprostenol 500 mcg excipient: arginine sodium hydroxide sucrose - veletri is indicated for the long-term treatment, via continuous intravenous infusion, in who functional class iii and iv patients with: · idiopathic pulmonary arterial hypertension · familial pulmonary arterial hypertension · pulmonary arterial hypertension associated with the scleroderma spectrum of diseases.

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

janssen-cilag pty ltd - epoprostenol sodium, quantity: 531 microgram (equivalent: epoprostenol, qty 500 microgram) - powder - excipient ingredients: arginine; sodium hydroxide; sucrose - veletri is indicated for the long-term treatment, via continuous intravenous infusion, in who functional class iii or class iv patients with:,? idiopathic pulmonary arterial hypertension,? familial pulmonary arterial hypertension,? pulmonary arterial hypertension associated with the scleroderma spectrum of diseases